← brief for 2026-08-13 · Slowing decline

SGLT2 inhibitors and secondary polycythemia: a systematic review and meta-analysis of hematologic effects in patients with type 2 diabetes.

Article B Peer reviewed Small trial

Key takeaways

SGLT2 inhibitors may increase hemoglobin and hematocrit levels. This meta-analysis of 5 trials with 1,000+ patients found a significant increase in hemoglobin.

Who did this work

Ali EAH · Rabadi M · Aweer RA · Subahi E · Abdelmahmuod EA · Alshurafa A · Abdulgayoom M · Mudarres MF · Elshaikh U · Al-Mashdali A · Mohamed S

Source

Article · PubMed, the drug frontier · 2026 Aug 13
https://pubmed.ncbi.nlm.nih.gov/42587114/